Michael J. Alberti - Concepedia

Author

Michael J. Alberti

Also Known As

M. J. ALBERTI, Michael J. Alberti

Publications

255

Citations

H-Index

Concepts

All Affiliations

Michael J. Alberti is an author at Research Triangle Park Foundation specializing in medicine, drug discovery, and pharmacotherapy.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	207
2	Natural Sciences	3	3	175
3	Biochemistry	3	3	164
4	Engineering	1	1	45
5	Biomolecular Engineering	1	1	45

Michael J. Alberti

Publications

252

Citations

H-Index

Page 1

	Year	Citations
Pyrazolo[1,5-a]pyridines as p38 Kinase Inhibitors Kirk L. Stevens, David Jung, Michael J. Alberti, Organic Letters Medicinal ChemistryHeterocyclicP38 Kinase InhibitorsBiochemistryMedicine	2005	87
Tandem Glycolate Claisen Rearrangement/Ring-Closing Metathesis: A Stereochemically General Synthesis of Substituted Dihydropyran-2-carboxylates Steven D. Burke, Raymond A. Ng, J. A. Morrison, The Journal of Organic Chemistry Stereochemically General SynthesisDiversity Oriented SynthesisEngineeringClaisen RearrangementNatural Sciences	1998	45
The identification of pyrazolo[1,5-a]pyridines as potent p38 kinase inhibitors Mui Cheung, Philip A. Harris, Jennifer G. Badiang, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesRational Drug Design	2008	43
(1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: A novel class of potent MSK-1-inhibitors Mark J. Bamford, Michael J. Alberti, Nicholas Bailey, Bioorganic & Medicinal Chemistry Letters -1,2,5-Oxadiazol-3-ylamine DerivativesMedicinal ChemistryMedicineMechanism Of ActionPharmacological Agent	2005	43
Discovery and in vitro evaluation of potent kinase inhibitors: Pyrido[1′,2′:1,5]pyrazolo[3,4-d]pyrimidines Michael J. Alberti, Elizabeth P. Auten, Karen Lackey, Bioorganic & Medicinal Chemistry Letters Drug TargetBiochemistryMedicineRational Drug DesignPharmacological Agent	2005	34

Page 1